tirzepatide 是 什么 新一代處方藥物Mounjaro(滿健樂,Tirzepatide),是全球首款GLP-1/GIP雙效受體促效劑。 一針雙效:針對第二型糖尿病及慢性體重管理 Tirzepatide | CAS No. 2023788-19-2
Pay in 4 interest-free payments of $6.90 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14




























